Andrea C Haynes

Summary

Affiliation: GlaxoSmithKline Research and Development
Country: USA

Publications

  1. ncbi request reprint Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice
    Andrea C Haynes
    GlaxoSmithKline, Third Avenue, Harlow, Essex, CM19 5AW, UK
    Regul Pept 104:153-9. 2002
  2. ncbi request reprint Orexins and the treatment of obesity
    Darren Smart
    Neurology CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK
    Eur J Pharmacol 440:199-212. 2002

Detail Information

Publications2

  1. ncbi request reprint Anorectic, thermogenic and anti-obesity activity of a selective orexin-1 receptor antagonist in ob/ob mice
    Andrea C Haynes
    GlaxoSmithKline, Third Avenue, Harlow, Essex, CM19 5AW, UK
    Regul Pept 104:153-9. 2002
    ..OX1 receptor mRNA was detected in BAT, and its expression was increased by 58% by treatment with SB-334867-A. This is the first demonstration that OX1 receptor antagonists have potential as both anti-obesity and anti-diabetic agents...
  2. ncbi request reprint Orexins and the treatment of obesity
    Darren Smart
    Neurology CEDD, GlaxoSmithKline, New Frontiers Science Park, Third Avenue, Harlow, Essex CM19 5AW, UK
    Eur J Pharmacol 440:199-212. 2002
    ....